The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Expected Market Size Of The Intravenous Therapy Solutions Market From 2026 To 2030?
The intravenous therapy solutions market has experienced substantial growth in recent years. It is projected to increase from $13.17 billion in 2025 to $14.53 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.3%. The historical expansion of this market can be attributed to factors like the development of hospital infrastructure, a rising occurrence of dehydration and electrolyte imbalance, the growing adoption of IV therapy in clinics, continuous technological advancements in IV solutions, and an increase in surgical procedures.
The intravenous therapy solutions market is anticipated to experience substantial growth in the upcoming years, with projections indicating it will attain a size of $21.25 billion by 2030, growing at a compound annual growth rate (CAGR) of 10.0%. This expansion during the forecast period can be attributed to several factors, including the increasing embrace of home healthcare, a heightened demand for personalized nutrition and medication delivery, the integration of technology with digital health platforms, the broadening of markets in emerging economies, and advancements in chronic disease management. Noteworthy trends during this period are expected to feature customized IV therapy solutions, the development of portable and home-based IV devices, improved infection control and safety protocols, sophisticated electrolyte and nutrient formulations, and their integration with electronic health records (EHR).
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25802&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Intravenous Therapy Solutions Market?
The increasing demand for minimally invasive therapies is projected to fuel the expansion of the intravenous therapy solutions market. Minimally invasive therapies are medical treatments characterized by minimal incisions or insertions into the body, often resulting in faster recovery and fewer complications. This rising demand for minimally invasive therapies is attributed to their capacity to lessen postoperative pain, which contributes to quicker patient recovery and greater overall comfort during the healing process. Intravenous therapy solutions play a supportive role in minimally invasive therapies by enabling the efficient delivery of essential fluids, medications, and nutrients directly into the bloodstream, thereby ensuring optimal patient care and more rapid recovery. For example, in June 2024, the American Society of Plastic Surgeons, a US-based non-profit organization, stated that minimally invasive procedures grew by 7% in 2023, exceeding surgical procedures by 2%. Hence, the growing demand for minimally invasive therapies is a key driver for the intravenous (IV) therapy solutions market’s growth.
Which Segments Are Included In The Analysis Of The Intravenous Therapy Solutions Market?
The intravenous therapy solutions market covered in this report is segmented –
1) By Product Type: Crystalloids, Colloids, Blood Products, Other Product Types
2) By Application: Fluid And Electrolyte Imbalance, Nutritional Support, Medication Administration, Blood Transfusion, Other Applications
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Other End-Users
Subsegments:
1) By Crystalloids: Normal Saline (0.9% Sodium Chloride), Half Normal Saline (0.45% Sodium Chloride), Lactated Ringer’s Solution, Dextrose Solutions, Hypertonic Saline
2) By Colloids: Albumin, Dextran, Hydroxyethyl Starch (HES), Gelatin
3) By Blood Products: Packed Red Blood Cells (PRBCs), Platelets, Fresh Frozen Plasma (FFP), Cryoprecipitate
4) By Other Product Types: Intravenous Immunoglobulins (IVIG), Parenteral Nutrition Solutions, Specialty Intravenous Drugs And Additives
Which Trends Are Impacting The Growth Of The Intravenous Therapy Solutions Market?
Major companies within the intravenous therapy solutions market are increasingly focusing on developing innovative solutions, such as ready-to-use drug infusions, to boost treatment efficiency and cut down preparation time in clinical environments. A ready-to-use drug infusion refers to pre-mixed, pre-labeled intravenous (IV) medications prepared in standardized doses and packaging, eliminating the requirement for on-site compounding or dilution. For example, in May 2024, B. Braun Medical Inc., a US-based manufacturing firm, introduced Levetiracetam in Sodium Chloride Injection, an immediately usable intravenous anticonvulsant solution. This product is specifically designed for treating seizures and is supplied in standardized concentrations and volumes, removing the need for dilution or compounding at the point of care. The Levetiracetam IV formulation, pre-mixed within a flexible container, ensures accurate dosing, minimizes contamination risks, and improves convenience for healthcare professionals across emergency and inpatient settings.
Which Key Industry Participants Are Active In The Intravenous Therapy Solutions Market?
Major companies operating in the intravenous therapy solutions market are Pfizer Inc., Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Dr. Reddy’s Laboratories Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, Biocon Limited, B. Braun Melsungen Aktiengesellschaft, JW Life Science Corporation, AdvaCare Pharma USA, Soxa Formulations & Research Pvt. Ltd., Vifor Pharma Management Ltd., Aetos Pharma Private Limited, LXIR Medilabs Private Limited, Amanta Healthcare Limited, Aculife Healthcare Private Limited, Claris Lifesciences Limited, Osel Lifesciences Pvt. Ltd., BBraun Avitum AG
Read the full intravenous therapy solutions market report here:
https://www.thebusinessresearchcompany.com/report/intravenous-therapy-solutions-global-market-report
What Are The Leading Geographic Regions In The Intravenous Therapy Solutions Market?
North America was the largest region in the intravenous therapy solutions market in 2025. The regions covered in the intravenous therapy solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Intravenous Therapy Solutions Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=25802&type=smp
Browse Through More Reports Similar to the Global Intravenous Therapy Solutions Market 2026, By The Business Research Company
Preventive Healthcare Technologies And Services Market Report 2026
Endotracheal Tubes Market Report 2026
https://www.thebusinessresearchcompany.com/report/endotracheal-tubes-global-market-report
Clinical Trial Equipment And Ancillary Solutions Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model